Non-pharmaceutical infection prevention measures in nosocomial SARS-CoV-2 outbreaks: a retrospective multicentre cohort study.

COVID-19 SARS-CoV-2 cluster healthcare-associated infection infection control nosocomial infection outbreak

Journal

The Journal of hospital infection
ISSN: 1532-2939
Titre abrégé: J Hosp Infect
Pays: England
ID NLM: 8007166

Informations de publication

Date de publication:
10 Oct 2024
Historique:
received: 18 04 2024
revised: 09 09 2024
accepted: 28 09 2024
medline: 13 10 2024
pubmed: 13 10 2024
entrez: 12 10 2024
Statut: aheadofprint

Résumé

Hospital severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreaks are relevant for patients and healthcare systems within and beyond the pandemic. We aimed to explore the characteristics of SARS-CoV-2 outbreaks and their infection prevention and control (IPC) measures during the different pandemic waves. A comprehensive structured template for SARS-CoV-2 outbreaks was developed and filled out by six university hospitals. The main outcome variable was outbreak size (OS). A total of 80 outbreaks and 734 infection cases were enrolled between 03/2020-02/2023. In the majority of outbreaks (85%) a contact tracing (CT) team was in place. In 13 (16%) outbreaks the CT team was exclusively responsible for CT, which was negatively linked to OS when adjusting for SARS-CoV-2 waves (Estimate (β)=-1.350; Standard Error (SE) =.274; p<0 .0001). Patients as index had a greater association with OS than healthcare workers (HCWs) (β=-0.29; SE=0.098; p=0.003). Additionally, the mandatory use of facemasks by patients in the presence of HCWs was negatively linked to OS (β=-0.237; SE=0.08; p=0.003). The frequency of patient screening during outbreaks varied considerably, whereby higher frequency screenings for SARS-CoV-2 were negatively associated with OS (β=-0.358; SE=0.109; p=0.001). Our data provides insights in non-pharmaceutical outbreak prevention and management revealing that the mandatory use of facemasks by patients in the presence of HCWs and a high patient screening frequency in ongoing outbreaks were significantly associated with smaller outbreaks. Further studies are required to allow for generalizability.

Identifiants

pubmed: 39395462
pii: S0195-6701(24)00330-X
doi: 10.1016/j.jhin.2024.09.021
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest none.

Auteurs

Isabella Dresselhaus (I)

Department for Infection Control and Infectious Diseases University Medical Center Göttingen, Georg-August University Göttingen, Göttingen, Germany. Electronic address: Isabella.dresselhaus@med.uni-goettingen.de.

Claas Baier (C)

Institute for Medical Microbiology and Hospital Epidemiology, Hannover Medical School, Hannover, Germany.

Nicolas Reinoso Schiller (N)

Department for Infection Control and Infectious Diseases University Medical Center Göttingen, Georg-August University Göttingen, Göttingen, Germany.

Annika Brodzinski (A)

Institute of Hygiene and Environmental Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.

Milena Berens (M)

Department for Infection Control and Infectious Diseases University Medical Center Göttingen, Georg-August University Göttingen, Göttingen, Germany.

Monika Cristofolini (M)

Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany; Hygiene and Infection Control, BG Hospital Bergmannstrost Halle, Halle, Germany.

Petra Gastmeier (P)

Institute of Hygiene and Environmental Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.

Christine Geffers (C)

Institute of Hygiene and Environmental Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.

Barbara Gärtner (B)

Institute of Medical Microbiology and Hygiene, Department of Hospital Hygiene, Saarland University, Homburg, Germany.

Frank Kipp (F)

Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany.

Nico T Mutters (NT)

Institute for Hygiene and Public Health, University Hospital Bonn, Bonn, Germany.

Alexander Daniel Wollkopf (AD)

Institute for Hygiene and Public Health, University Hospital Bonn, Bonn, Germany.

Cihan Papan (C)

Institute for Hygiene and Public Health, University Hospital Bonn, Bonn, Germany.

Simone Scheithauer (S)

Department for Infection Control and Infectious Diseases University Medical Center Göttingen, Georg-August University Göttingen, Göttingen, Germany.

Classifications MeSH